Search Results - "Rubio, Andres J."

Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B by Bencomo-Alvarez, Alfonso E., Rubio, Andres J., Olivas, Idaly M., Gonzalez, Mayra A., Ellwood, Rebecca, Fiol, Carme Ripoll, Eide, Christopher A., Lara, Joshua J., Barreto-Vargas, Christian, Jave-Suarez, Luis F., Nteliopoulos, Georgios, Reid, Alistair G., Milojkovic, Dragana, Druker, Brian J., Apperley, Jane, Khorashad, Jamshid S., Eiring, Anna M.

“…Tyrosine kinase inhibitors (TKIs) targeting BCR-ABL1 have revolutionized therapy for chronic myeloid leukemia (CML), paving the way for clinical development in…”
Get full text

19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML) by Lara, Joshua J, Bencomo-Alvarez, Alfonso E, Gonzalez, Mayra A, Olivas, Idaly M, Young, James E, Lopez, Jose L, Velazquez, Vanessa V, Glovier, Steven, Keivan, Mehrshad, Rubio, Andres J, Dang, Sara K, Solecki, Jonathan P, Allen, Jesse C, Tapia, Desiree N, Tychhon, Boranai, Astudillo, Gonzalo E, Jordan, Connor, Chandrashekar, Darshan S, Eiring, Anna M

“…26S proteasome non-ATPase subunits 1 (PSMD1) and 3 (PSMD3) were recently identified as prognostic biomarkers and potential therapeutic targets in chronic…”
Get full text

26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy by Rubio, Andres J., Bencomo-Alvarez, Alfonso E., Young, James E., Velazquez, Vanessa V., Lara, Joshua J., Gonzalez, Mayra A., Eiring, Anna M.

“…Ever since the ubiquitin proteasome system was characterized, efforts have been made to manipulate its function to abrogate the progression of cancer. As a…”
Get full text

The prognostic value of 19S ATPase proteasome subunits in acute myeloid leukemia and other forms of cancer by Tychhon, Boranai, Allen, Jesse C, Gonzalez, Mayra A, Olivas, Idaly M, Solecki, Jonathan P, Keivan, Mehrshad, Velazquez, Vanessa V, McCall, Emily B, Tapia, Desiree N, Rubio, Andres J, Jordan, Connor, Elliott, David, Eiring, Anna M

“…The ubiquitin-proteasome system (UPS) is an intracellular organelle responsible for targeted protein degradation, which represents a standard therapeutic…”
Get full text

Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism by Gonzalez, Mayra A., Olivas, Idaly M., Bencomo‐Alvarez, Alfonso E., Rubio, Andres J., Barreto‐Vargas, Christian, Lopez, Jose L., Dang, Sara K., Solecki, Jonathan P., McCall, Emily, Astudillo, Gonzalo, Velazquez, Vanessa V., Schenkel, Katherine, Reffell, Kelaiah, Perkins, Mariah, Nguyen, Nhu, Apaflo, Jehu N., Alvidrez, Efren, Young, James E., Lara, Joshua J., Yan, Dongqing, Senina, Anna, Ahmann, Jonathan, Varley, Katherine E., Mason, Clinton C., Eide, Christopher A., Druker, Brian J., Nurunnabi, Md, Padilla, Osvaldo, Bajpeyi, Sudip, Eiring, Anna M.

“…Tyrosine kinase inhibitors (TKIs) targeting BCR::ABL1 have turned chronic myeloid leukaemia (CML) from a fatal disease into a manageable condition for most…”
Get full text

Energy metabolism and drug response in myeloid leukaemic stem cells by Bencomo‐Alvarez, Alfonso E., Rubio, Andres J., Gonzalez, Mayra A., Eiring, Anna M.

“…Summary Despite significant advances in the treatment of myeloid malignancies, many patients become resistant to therapy and ultimately succumb to their…”
Get full text

Ethnic and border differences on blood cancer presentation and outcomes: A Texas population‐based study by Bencomo‐Alvarez, Alfonso E., Gonzalez, Mayra A., Rubio, Andres J., Olivas, Idaly M., Lara, Joshua J., Padilla, Osvaldo, Orazi, Attilio, Corral, Javier, Philipovskiy, Alexander, Gaur, Sumit, Mulla, Zuber D., Dwivedi, Alok K., Eiring, Anna M.

“…Background The Texas/Chihuahua (US/Mexico) border is a medically underserved region with many reported barriers for health care access. Although Hispanic…”
Get full text

Large Peritoneal Macrophages and Transitional Premonocytes Promote Survival during Abdominal Sepsis by Goswami, Dinesh G, Rubio, Andres J, Mata, Jenna, Munoz, Soraida, Gallegos, Alejandra, Walker, Wendy E

“…Monocytes and macrophages are early sentinels of infection. The peritoneum contains two resident populations: large and small peritoneal macrophages (LPMs and…”
Get full text

Blood cancer health disparities in the United States Hispanic population by Bencomo-Alvarez, Alfonso E, Rubio, Andres J, Gonzalez, Mayra A, Eiring, Anna M

“…Cancer is a challenging, multifaceted disease that involves a combination of biological and nonbiological factors. Aside from COVID-19, cancer is the second…”
Get full text

Abstract P150: PSMD1 and PSMD3 as putative targets for cancer therapy by Rubio, Andres J., Bencomo-Alvarez, Alfonso E., Young, James E., Velazquez, Vanessa V., Eiring, Anna M.

“…Ever since the ubiquitin proteasome system was characterized, efforts have been made to manipulate its function to abrogate the progression of cancer. As a…”
Get full text

Regulation of Oxidative Energy Metabolism By G0S2 in FLT3+ AML by Gonzalez, Mayra A., Lopez, Jose L., Velazquez, Vanessa V., Perkins, Mariah, Olivas, Idaly M., Bencomo, Alfonso E., Rubio, Andres J., Apaflo, Jehu N., Bajpeyi, Sudip, Eiring, Anna M.

Get full text

19S Proteasome Subunits As Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML) by Lara, Joshua J., Bencomo, Alfonso E., Gonzalez, Mayra A., Olivas, Idaly M., Lopez, Jose L., Young, James E., Velazquez, Vanessa V., Glovier, Steven, Rubio, Andres J., Dang, Sara K., Solecki, Jonathan, Allen, Jesse, Tapia, Desiree N., Tychhon, Boranai, Astudillo, Gonzalo E., Chandrashekar, Darshan S., Eiring, Anna M.

Get full text

Abstract 647: NF-kB associates with tyrosine kinase inhibitor resistance in chronic myeloid leukemia by Rubio, Andres J., Olivas, Idaly M., Bencomo, Alfonso E., Gonzalez, Mayra A., Lara, Joshua J., Ellwood, Rebecca, Ripoll-Fiol, Carme, Nteliopoulos, Georgios, Reid, Alistair, Milojkovic, Dragana, Apperley, Jane, Sorouri-Khorashad, Jamshid, Eiring, Anna M.

“…Tyrosine kinase inhibitors (TKIs) targeting BCR-ABL1 are effective at eliminating most BCR-ABL1+ cells in chronic myeloid leukemia (CML), but do not target CML…”
Get full text

Abstract 4343: Retrospective study of incidence and survival for patients with hematological malignancies residing at the U.S./Mexico border by Bencomo, Alfonso E., Rubio, Andres J., Gonzalez, Mayra A., Olivas, Idaly M., Lara, Joshua J., Ghimire, Kiran, Padilla, Osvaldo, Padilla, Angelica, Hakim, Nawar, Orazi, Attilio, Corral, Javier, Philipovskiy, Alexander, Gaur, Sumit, Eiring, Anna M.

“…Introduction: Hispanics represent the largest minority group in the United States (U.S.), with 57.5 million individuals. The majority of Hispanics in the U.S…”
Get full text

Abstract 648: Role of G0S2 in chronic myeloid leukemia and TKI resistance by Gonzalez, Mayra A., Bencomo, Alfonso E., Barreto-Vargas, Christian, Rubio, Andres J., Olivas, Idaly M., Lara, Joshua J., Senina, Anna, Ahmann, Jonathan, Varley, Katherine T., Jave-Suarez, Luis F., Thomas, O'Hare, Deininger, Michael W., Eiring, Anna M.

“…Tyrosine kinase inhibitors (TKIs) targeting BCR-ABL1 have turned chronic myeloid leukemia (CML) from a fatal to a chronic disease. However, resistance is a…”
Get full text

Proteasome 26S subunit, non-ATPases 1 , play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B by Bencomo-Alvarez, Alfonso E, Rubio, Andres J, Olivas, Idaly M, Gonzalez, Mayra A, Ellwood, Rebecca, Fiol, Carme Ripoll, Eide, Christopher A, Lara, Joshua J, Barreto-Vargas, Christian, Jave-Suarez, Luis F, Nteliopoulos, Georgios, Reid, Alistair G, Milojkovic, Dragana, Druker, Brian J, Apperley, Jane, Khorashad, Jamshid S, Eiring, Anna M

“…Tyrosine kinase inhibitors (TKIs) targeting BCR-ABL1 have revolutionized therapy for chronic myeloid leukemia (CML), paving the way for clinical development in…”
Get full text

NF-κB-Dependent Activation of the Proteasome Components, PSMD1 and PSMD3, As a Mechanism of Resistance to Imatinib by Olivas, Idaly Maria, Lara, Joshua, Ellwood, Rebecca, Ripoll Fiol, Carme, Rubio, Andres J, Bencomo, Alfonso Enrique, Gonzalez, Mayra Alejandra, Nteliopoulos, Georgios, Reid, Alistair, Milojkovic, Dragana, Apperley, Jane, Sorouri Khorashad, Jamshid, Eiring, Anna M.

“…Tyrosine kinase inhibitors (TKIs) targeting BCR-ABL1 are remarkably effective therapies in chronic myeloid leukemia (CML). Despite clinical success, TKIs do…”
Get full text

Retrospective Study of Incidence and Survival for Patients with Hematologic Malignancies Residing at the U.S./Mexico Border by Bencomo, Alfonso Enrique, Rubio, Andres J, Gonzalez, Mayra Alejandra, Olivas, Idaly Maria, Lara, Joshua, Ghimire, Kiran, Padilla, Osvaldo, Padilla, Angelica, Hakim, Nawar, Orazi, Attilio, Corral, Javier, Philipovskiy, Alexander, Gaur, Sumit, Eiring, Anna M.

“…Introduction: Hispanics represent the largest minority group in the United States (U.S.), with 57.5 million individuals (18% of the population). Most U.S…”
Get full text

Strain-induced band gap engineering in layered TiS3 by Biele, Robert, Flores, Eduardo, Ares, Jose Ramón, Sanchez, Carlos, Ferrer, Isabel J., Rubio-Bollinger, Gabino, Castellanos-Gomez, Andres, D’Agosta, Roberto

“…By combining ab initio calculations and experiments, we demonstrate how the band gap of the transition metal trichalcogenide TiS3 can be modified by inducing…”
Get full text